Results 181 to 190 of about 6,860 (236)
Some of the next articles are maybe not open access.

Clinical Efficacy of Doripenem in Treating Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis

THE ULUTAS MEDICAL JOURNAL, 2022
This meta-analysis investigated whether the clinical efficacy of doripenem is comparable to that of alternative antibiotics for treating hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Kun-Ji Wu, C. Chao, Guang-Mao Lee
semanticscholar   +1 more source

Evaluating the efficacy of doripenem against Staphylococcus aureus in vancomycin-resistant strains

Microbial Pathogenesis
Determination of antibiotic susceptibility is a crucial aspect of antimicrobial therapy. The objective of this study was to determine the specific susceptibility of Staphylococcus aureus (SA) to the antibiotic doripenem.
Pitchiah Sivaperumal   +2 more
exaly   +2 more sources

Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales

Journal of chemotherapy, 2020
This study aims to analyze the effect of ceftazidime/avibactam plus various antibiotics against OXA-48-producing Enterobacterales isolated from Intensive Care Units.
Emel Mataracı Kara   +3 more
semanticscholar   +1 more source

Doripenem

Reactions Weekly, 2016
Mark G. Papich
semanticscholar   +3 more sources

Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

open access: yesDiagnostic Microbiology and Infectious Disease, 2009
The in vitro activity of doripenem against prevalent nonfermentative Gram-negative bacilli and Aeromonas spp. was evaluated. The collection comprised 14979 nonduplicate clinical isolates submitted during a global Doripenem Surveillance Program conducted ...
Mariana Castanheira   +2 more
exaly   +2 more sources

Doripenem: antimicrobial profile and clinical potential

Diagnostic Microbiology and Infectious Disease, 2009
David M Livermore
exaly   +4 more sources

Stability-indicating HPLC method optimization using quality by design with design of experiments approach for quantitative estimation of organic related impurities of Doripenem in pharmaceutical formulations

Journal of Applied Pharmaceutical Sciences
Doripenem (DM), an antibiotic used for kidney, lung, and urinary infections, underwent the development of a robust high-performance liquid chromatography (HPLC) technique using the quality-by-design approach.
N. V. V. D. P. Boppy   +7 more
semanticscholar   +1 more source

Doripenem for Injection

Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada   +3 more
openaire   +1 more source

Innovative ultra-sensitive spectrofluorimetric method for nanogram detection of doripenem monohydrate in human plasma, urine and pharmaceutical formulation

Microchemical journal (Print), 2019
Doripenem monohydrate (DOR), is a recently FDA approved β- lactam antibiotic. DOR belongs to carbapenems class and it is used for the treatment of several diseases caused by different strains of bacteria.
Baher I. Salman   +3 more
semanticscholar   +1 more source

Doripenem: A new carbapenem antibiotic

American Journal of Health-System Pharmacy, 2010
The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed.Doripenem, a member of the β-lactam class of antibiotics, is the newest addition to the carbapenems.
Elias B, Chahine   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy